Faced with Aggression from Medtronic and Johnson & Johnson, How Does Intuitive Surgical Defend Its Monopoly? Apr 8, 2026 Life Science
Eli Lilly Writes a Check. AC Immune Surges 15%. Is This Strategy or Spare Change? Apr 7, 2026 Life Science
Wave Life Sciences’ Weight Loss Drug Phase 1 Clinical Data Triggers Stock Volatility, Yet Differentiated Path Still Shows Promise Apr 1, 2026 Life Science
Impressive Performance Yet Low Stock Price, Can Eli Lilly Usher in a Turning Point with Medicare Coverage? Mar 31, 2026 Life Science
This Popular ETF Quietly Boosted Its Healthcare Stake – High-Yield Dividend Stocks Are the New Favorite Mar 31, 2026 Life Science
Viking Therapeutics Approaches Make-or-Break Moment as Key GLP-1 Data Looms Mar 29, 2026 Life Science
Approved Catalyst Fuels Market Movement, Corcept Therapeutics Leads Healthcare Sector This Week Mar 27, 2026 Life Science
After Surging Over 100% in a Year, Executives Reduce Holdings Amid Adaptive Biotech’s Strong Performance Mar 27, 2026 Life Science
High Volatility, High Reward: Two Biotech Stocks for the Risk-Tolerant Investor Mar 26, 2026 Life Science
Under the Spotlight of GLP-1, the Hidden Risks of Eli Lilly’s High Valuation Cannot Be Ignored Mar 26, 2026 Life Science
